更年期
医学
体质指数
糖尿病
冲程(发动机)
逻辑回归
疾病
产科
内科学
内分泌学
机械工程
工程类
作者
Keiko Yamanouchi,Tsuyoshi Ohta,Tsuneo Konta,Fumihiro Nakamura,Shouta Horikawa,Nanako Nakai,Kazuyoshi Sakai,Mika Fukase,Manabu Seino,Hizuru Yamatani,Masafumi Watanabe,Yoshiyuki Ueno,Satoru Nagase
出处
期刊:Menopause
[Lippincott Williams & Wilkins]
日期:2022-07-01
卷期号:29 (7): 850-855
被引量:1
标识
DOI:10.1097/gme.0000000000001987
摘要
Abstract Objective The primary objective was to investigate the association between early menopause and cardiovascular disease (CVD) prevalence in Japanese women. The secondary objective was to ascertain the association with CVD risk factors. Methods In this cross-sectional study, 7,239 naturally menopausal women from the Yamagata Cohort Study who completed an annual health visit and questionnaire between 2009 and 2015 were divided into three groups according to their age at menopause (women experiencing menopause at <45, 45-49 y, and ≥ 50 y). The diagnosis of coronary heart disease (CHD) and stroke were made by self-report, while hypertension, hyperlipidemia, and diabetes mellitus, were diagnosed by vital signs and laboratory parameters. Logistic regression analysis was used to estimate the associations between age at menopause and CVD prevalence and CVD risk factors. Results A total of 354 (4.9%) and 156 (2.2%) women reported a history of CHD and stroke, respectively. Women experiencing menopause at <45 years had a higher prevalence of CHD than those experiencing menopause at ≥50 years (OR 1.77, 95% CI 1.07-2.90; P = 0.023). Stroke, hypertension, diabetes mellitus, and hyperlipidemia were equally prevalent among the three groups. Significant interactions were observed between age at menopause and body mass index (BMI) ( P = 0.025) and parity ( P = 0.025). Among those with a BMI < 18.5 or parity ≥2, women experiencing menopause at <45 years had a significantly higher prevalence of CHD than those experiencing menopause at ≥50 years. Conclusion Early menopause and low BMI were associated with CHD in Japanese women.
科研通智能强力驱动
Strongly Powered by AbleSci AI